Phytochemical and antiinflammatory studies on Terminalia catappa

Fitoterapia

Volumn 75, Issue 3-4, 2004, Pages 253-260

  Fan, Y M ^a   Xu, L Z ^a   Gao, J ^a   Wang, Y ^a   Tang, X H ^a   Zhao, X N ^a   Zhang, Z X ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

12 O Tetradecanoylphorbol 13 acetate; 2 ,3 ,23 Trihydroxyurs 12 en 28 oic acid; Terminalia catappa; Topical antiinflammatory activity; Ursolic acid

Indexed keywords

ALCOHOL; ANTIINFLAMMATORY AGENT; ASIATIC ACID; CHLOROFORM; HERBACEOUS AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PLANT EXTRACT; TERMINALIA CATAPPA EXTRACT; UNCLASSIFIED DRUG; URSOLIC ACID;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOASSAY; CHRONIC DISEASE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; EAR DISEASE; EDEMA; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PRIORITY JOURNAL; TERMINALIA; TERMINALIA CATAPPA;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; MALE; MICE; MICE, INBRED ICR; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; TERMINALIA; TETRADECANOYLPHORBOL ACETATE;

TERMINALIA; TERMINALIA CATAPPA;

EID: 2442667447     PISSN: 0367326X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fitote.2003.11.007     Document Type: Article

References (17)

1. Lin C.C., Chen Y.L., Lin J.M., Ujiie T. Am J Chin Med. 25:(2):1997;153
2. Lin C.C., Hsu Y.F., Lin T.C., Hsu F.L., Hsu H.Y. J Pharm Pharmacol. 50:1998;789
3. Lin C.C., Hsu Y.F., Lin T.C. Am J Chin Med. 27:(3-4):1999;371
4. Chen P.S., Li J.H., Liu T.Y., Lin T.C. Cancer Lett. 152:2000;115
5. Tanaka T., Nonaka G., Itsuo N. Chem Pharm Bull. 34:1986;1039
6. Mau J.L., Ko P.T., Chyau C.C. Food Res Int. 36:2003;97
7. Budzikiewicz H., Wilson J.M., Djerassi C. J Am Chem Soc. 85:1963;3688
8. Doddrell D.M., Khong P.W., Lewis K.G. Tetrahedron Lett. 1974;2381
9. Kojima H., Ogura H. Phytochemistry. 25:1986;729
10. Mahato S.B., Kundu A.P. Phytochemistry. 37:1994;1517
11. De Young L.M., Kheifets J.B., Ballaron S.J., Young J.M. Agents Actions. 26:1989;335
12. Máñez S., Recio M.C., Giner R.M., Ríos J.L. Eur J Pharmacol. 334:1997;103
13. Giner R.M., Villalba M.L., Recio M.C., Máñez S., Cerdá M., Ríos J.L. Eur J Pharmacol. 389:2000;243
14. Huguet A.I., Recio M.C., Máñez S., Giner R.M., Ríos J.L. Eur J Pharmacol. 410:2000;69
15. Giner E.M., Máñez S., Recio M.C., Giner R.M., Prieto J.M., Cerdá M., Ríos J.L. Eur J Pharmacol. 428:2001;137
16. Huang M.T., Ho C.T., Wang Z.Y., Ferraro T., Lou Y.R., Stauber K., Ma W. Cancer Res. 54:1994;701
17. Máñez S., Recio M.C., Giner R.M., Ríos J.L. Eur J Pharmacol. 334:1997;103